8 analysts have expressed a variety of opinions on Inspire Medical Systems INSP over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 4 | 3 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 1 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 1 | 3 | 2 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $231.12, a high estimate of $260.00, and a low estimate of $190.00. This upward trend is evident, with the current average reflecting a 4.58% increase from the previous average price target of $221.00.
Investigating Analyst Ratings: An Elaborate Study
A comprehensive examination of how financial experts perceive Inspire Medical Systems is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Brett Fishbin | Keybanc | Lowers | Overweight | $234.00 | $236.00 |
| Jonathan Block | Stifel | Lowers | Hold | $190.00 | $200.00 |
| Bob Hopkins | B of A Securities | Raises | Buy | $255.00 | $220.00 |
| Shagun Singh | RBC Capital | Maintains | Outperform | $260.00 | $260.00 |
| Adam Maeder | Piper Sandler | Raises | Overweight | $260.00 | $255.00 |
| Jonathan Block | Stifel | Raises | Hold | $200.00 | $170.00 |
| Larry Biegelsen | Wells Fargo | Raises | Equal-Weight | $198.00 | $187.00 |
| Mike Polark | Baird | Raises | Outperform | $252.00 | $240.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Inspire Medical Systems. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Inspire Medical Systems compared to the broader market.
- Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Inspire Medical Systems's stock. This examination reveals shifts in analysts' expectations over time.
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Inspire Medical Systems's market position. Stay informed and make well-informed decisions with our Ratings Table.
Stay up to date on Inspire Medical Systems analyst ratings.
Unveiling the Story Behind Inspire Medical Systems
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Financial Milestones: Inspire Medical Systems's Journey
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Over the 3 months period, Inspire Medical Systems showcased positive performance, achieving a revenue growth rate of 32.54% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Inspire Medical Systems's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 9.1%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Inspire Medical Systems's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 2.77%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Inspire Medical Systems's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 2.43%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Inspire Medical Systems's debt-to-equity ratio is below the industry average. With a ratio of 0.04, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
The Basics of Analyst Ratings
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
